Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

CVS Health said it will restore coverage of Eli Lilly's blockbuster weight loss injection Zepbound and start covering its new obesity pill on its standard drug plans. The move supports Lilly's efforts ...

Eli Lilly currently holds a patent on both drugs through 2036.

GLP-1 medications can come with side effects—these are the vitamins and supplements that helped me navigate and manage them ...

All major US pharmacy benefit managers now cover Lilly's obesity treatments CVS includes Foundayo as a co-preferred weight-loss drug starting Monday It will restart Zepbound coverage on October 1 Sign ...

DSN's Senior Editor Sandra Levy caught up with Tanvi Patel, Amazon Pharmacy's vice president and GM, to discuss the importance of Amazon Pharmacy expanding access to Eli Lilly's Zepbound KwikPen for ...

If you want to talk to your health care provider about weight loss medications, Saxenda and Zepbound are two options you may ...

CVS Health’s (CVS) pharmacy benefit manager, CVS Caremark, announced on Thursday updates to its most common commercial formularies, including a decision to restore coverage for Eli Lilly’s (LLY) ...

Eli Lilly’s next-generation weekly weight-loss shot may be more effective than Zepbound or bariatric surgery, which has long been the gold standard for weight loss. In a Phase 3 trial, called ...

Meaghan is an editor and writer who also has experience practicing holistic medicine as an acupuncturist and herbalist. She's passionate about helping individuals live full, healthy and happy lives at ...